Keyword: hostile takeover bid
News
30.04.2015
- Still being pursued by Israeli generics giant Teva, Netherlands-based drugmaker Mylan has increased its offer to acquire the issued and to-be-issued shares of smaller generics...
News
28.04.2015
- In its first reaction to the hostile takeover bid by Israeli generics giant Teva, the board of Dutch-based drugmaker Mylan has unanimously rejected the more than $40 billion offer...
News
24.04.2015
- US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...
News
22.04.2015
- In what is shaping up to be the global pharmaceutical industry's latest hostile takeover struggle, the world's largest generic drugmaker, Israel-based Teva, has made a bid for...
News
04.11.2014
- Botox maker Allergan, which is fighting a hostile takeover bid by Valeant Pharmaceutical, is said to have been approached about a potential transaction by another party. The news...
